Cargando…
DRP1 promotes lactate utilization in KRAS‐mutant non‐small‐cell lung cancer cells
Metabolic alterations are well documented in various cancers. Non‐small‐cell lung cancers (NSCLCs) preferentially use lactate as the primary carbon source, but the underlying mechanisms are not well understood. We developed a lactate‐dependent cell proliferation assay and found that dynamin‐related...
Autores principales: | Hu, Mangze, Zhao, Yu, Cao, Yuejiao, Tang, Qianru, Feng, Ziqin, Ni, Jun, Zhou, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540982/ https://www.ncbi.nlm.nih.gov/pubmed/32767829 http://dx.doi.org/10.1111/cas.14603 |
Ejemplares similares
-
Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML
por: O’Brien, Gráinne, et al.
Publicado: (2020) -
AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2
por: Deng, Peng, et al.
Publicado: (2018) -
DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3
por: Zhang, Xue, et al.
Publicado: (2020) -
Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway
por: Lian, Jingyao, et al.
Publicado: (2020) -
Inactivation of homeodomain‐interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53‐dependent E‐cadherin expression
por: Zheng, Xueqing, et al.
Publicado: (2020)